https://doi.org/10.1038/s42003-022-03262-7
M
Madeleine F. Jennewein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
3.1K
Citations
18
h-index
24
i10-index
Madeleine F. Jennewein is an academic researcher from Advanced Energy (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Monoclonal and Polyclonal Antibodies Research & Animal Virus Infections Studies. The author has an h-index of 18, co-authored 39 publications.
ORCID: 0000-0001-6633-7413Papers by this author
worksStructural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
2022 · Communications Biology · 86 citations
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
2022 · npj Vaccines · 79 citations
https://doi.org/10.1038/s41541-022-00549-y
Functional and structural modifications of influenza antibodies during pregnancy
2022 · iScience · 16 citations
https://doi.org/10.1016/j.isci.2022.104088
Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
2025 · Molecular Therapy · 6 citations
https://doi.org/10.1016/j.ymthe.2025.04.007
Intranasal replicon vaccine establishes mucosal immunity and protects against H5N1 and H7N9 influenza
2026 · Nature Communications · 0 citations
https://doi.org/10.1038/s41467-025-64829-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat